Salavert José, Grados Dolors, Ramiro Nuria, Carrión Maria Isabel, Fadeuilhe Christian, Palma Felipe, López Laura, Erra Alba, Ramírez Nicolás
*Psychiatry Department, Hospital San Rafael, Vall d'Hebron University Hospital, FIDMAG Germanes Hosptalàries Research Foundation, CIBERSAM; and †Rheumatology Department, Hospital San Rafael, Barcelona, Spain.
J Nerv Ment Dis. 2017 May;205(5):409-412. doi: 10.1097/NMD.0000000000000670.
Vitamin D deficiency has been linked with schizophrenia. We aimed to determine whether patients with a first episode of psychosis (FEP) had lower vitamin D levels compared with controls considering their final diagnosis. We conducted a cross-sectional study determining 25-hydroxyvitamin D blood levels. 25-Hydroxyvitamin D levels were considered optimum at 20 ng/mL or greater. A group of 45 adult patients with FEP and a group of 22 healthy controls matched for age were recruited. The patient group was subdivided in two final diagnosis groups (schizophrenia versus other psychoses) after a 6-month follow-up. Average vitamin D values were deficient for FEP patients, especially those 22 with a final diagnosis of schizophrenia. These results relating vitamin D and schizophrenia generate interest to further examine this association.
维生素D缺乏与精神分裂症有关。我们旨在确定首次发作精神病(FEP)患者与对照组相比,考虑到他们的最终诊断,其维生素D水平是否更低。我们进行了一项横断面研究,测定25-羟基维生素D的血液水平。25-羟基维生素D水平在20 ng/mL及以上被认为是最佳的。招募了一组45名成年FEP患者和一组年龄匹配的22名健康对照。在6个月的随访后,患者组被分为两个最终诊断组(精神分裂症与其他精神病)。FEP患者的平均维生素D值不足,尤其是那些最终诊断为精神分裂症的22名患者。这些关于维生素D与精神分裂症的结果引发了进一步研究这种关联的兴趣。